arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Arcus Biosciences, Inc.

RCUS Health Care Biotechnology: Pharmaceutical Preparations
$23.19
▼ -6.1% Today
as of Jun 7, 07:25 ET
Last 30 days -6.49% Apr 28 → Jun 05
$22.49 $23.45 $24.40 $25.36 $26.32 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$24.27
High
$24.56
Low
$22.56
Volume
$856,057
Avg Vol
$1M
Mkt Cap
$3.1B
P/E (TTM)
Beta
52w High
$28.72
52w Low
$7.91
Div Yield
Shares Out
$126M

Overview

52-week range
$7.91
$29
73% of range
Avg surprise (last 2)
-11.3%
Avg reaction (last 2)
-4.6%
50% positive
Latest IV / EM
110%
EM ±15.2% · $23 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.27$-0.97$-0.66$-0.35$-0.05 Actual $-1.04Actual $-0.94Actual $-0.05Actual $-1.02Actual $-1.00Actual $-1.14Est $-1.02Actual $-1.27Actual $-1.02Est $-0.92 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-135M$-59M$16M$92M$168M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-1.02 $-0.92 -10.9% +10.5% +0.0% earnings
Tue Sep 30, 2025Sep 2025 $-1.27 financials
Mon Jun 30, 2025Jun 2025 financials
Tue May 6, 2025Mar/2025 $-1.14 $-1.02 -11.8% -9.2% earnings
Mon Sep 30, 2024Sep 2024 $-1.00 financials
Sun Jun 30, 2024Jun 2024 $-1.02 financials
Sun Mar 31, 2024Mar 2024 $-0.05 financials
Sat Sep 30, 2023Sep 2023 $-0.94 financials
Fri Jun 30, 2023Jun 2023 $-1.04 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$17M$26M$160M$28M$48M$39M
Cost of revenue
Gross profit
Operating income$-134M$-142M$-8M$-122M$-105M$-106M
Net income$-128M$-135M$0$-112M$-92M$-93M
EPS (diluted)$-1.02$-1.27$-1.14$-1.00$-1.02

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$201M$222M$238M$248M$192M$150M$201M$156M
Inventory
Total current assets$844M$1.01B$857M$946M$1.03B$1.02B$1.13B$1.02B
Total assets$997M$1.14B$974M$1.07B$1.16B$1.15B$1.25B$1.19B
Long-term debt$100M$99M$98M$97M$48M$48M$47M
Total liabilities
Total equity$524M$631M$436M$549M$531M$485M$565M$635M

Implied volatility — last 90 days

104%107%109%112%114% Jun 07 — IV 110% · EM ±15.2%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.